HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

cis-Diaminechloroplatinum in the treatment of advanced primary squamous cell carcinoma of the vaginal wall: a case report.

Abstract
A 34-year-old patient with advanced primary squamocellular vaginal carcinoma was treated with external radiation (4000 cGy to the pelvis) and a line source Cesium application delivering 4000 cGy to the vaginal wall. During this treatment the patient developed a lesion on her back that proved to be a metastasis of a squamocellular cancer. The patient was started on six courses of cisplatin as a single agent. After the fourth course a complete remission was reached lasting for 4 months. By that time the metastasis recurred and was surgically excised. Sixteen months after diagnosis and 9 months after chemotherapeutic treatment there is no evidence of disease.
AuthorsC A Holleboom, H C Kock, A M Nijs, W H Leers
JournalGynecologic oncology (Gynecol Oncol) Vol. 27 Issue 1 Pg. 110-5 (May 1987) ISSN: 0090-8258 [Print] United States
PMID3570044 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Cisplatin
Topics
  • Adult
  • Back
  • Carcinoma, Squamous Cell (drug therapy, radiotherapy)
  • Cisplatin (therapeutic use)
  • Female
  • Humans
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local
  • Skin Neoplasms (drug therapy, pathology, secondary, surgery)
  • Vaginal Neoplasms (drug therapy, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: